Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

REFRESH OPTIVE FUSION SENSITIVE - Health Canada Drug Approval Details

Approvals/Health Canada/REFRESH OPTIVE FUSION SENSITIVE

Authorized

STANDARD

REFRESH OPTIVE FUSION SENSITIVE

Allergan, Inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 1b952e6ac7a2c095
Company: Allergan, Inc.
Type: Standard

Approval Details

Approval Id: 1b952e6ac7a2c095
Drug Approval Canada Name: REFRESH OPTIVE FUSION SENSITIVE
Product Name: REFRESH OPTIVE FUSION SENSITIVE
Status: Cancelled Post Market
Status Date: 2024-06-20
Original Market Date: 2016-04-26
Din: 02450534
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: OTC
Ahfs: 52:13.00*
Atc Original: S01XA20 ARTIFICIAL TEARS AND OTHER INDIFFERENT PREPARATIONS.
Atc Name: s 01 xa 20
Aig Number: 0251696003
Company Name: Allergan, Inc.
Company Address: 300, 1380 Rodick Road, Markham, Ontario, Canada, L3R 4G5
Company Detail Path: /organization/allergan-inc

Company Information

Pharmaceutical Company Name: Allergan, Inc.
Name Zh: 艾尔建 (美国)
Country Name: United States
Province Name: Illinois
City Name: north chicago,illinois,country_us
Address: 1 N Waukegan Rd
Website: https://thespotlyte.com/index.html

Active Ingredients

GLYCERINE

1 % / W/V

CARBOXYMETHYLCELLULOSE SODIUM

0.5 % / W/V

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1b952e6ac7a2c095

Type

Standard

Back to Health Canada Approvals